February 6, 2017 / 1:38 PM / 6 months ago

BRIEF-Veracyte says Palmetto GBA has finalized coverage policy for percepta bronchial genomic classifier

1 Min Read

Feb 6 (Reuters) - Veracyte Inc

* Veracyte Inc - Palmetto GBA, a medicare administrative contractor (MAC), has finalized its coverage policy for percepta bronchial genomic classifier

* Veracyte Inc - developed through medicare moldx program, policy will become effective March 13, 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below